FindTrial
Sign In

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02503176
Enrollment
Unknown
Registered
2015-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2018-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye With Sjögren's Syndrome

Keywords

Dry eye syndromes, Corneal diseases, Conjunctival diseases

Brief summary

The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.

Interventions

DRUGKCT-0809 ophthalmic solution

Sponsors

Kissei Pharmaceutical Co., Ltd.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum

Inclusion criteria

* Dry eye patients with Sjögren's syndrome finished KCT1301 study

Exclusion criteria

* Patients with poor adherence to medication of study drug in KCT1301 study

Design outcomes

Primary

MeasureTime frame
Incidences of adverse events52 weeks

Secondary

MeasureTime frame
Score of the corneal staining52 weeks

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026